Anti-CD183/CXCR3 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22161; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-CD183/CXCR3 Polyclonal Antibody: A Powerful Tool for Targeted Biomedical Research
The Anti-CD183/CXCR3 Polyclonal Antibody is a highly specific and versatile tool for researchers in the biotechnology field. This antibody targets the CD183/CXCR3 protein, which plays a crucial role in immune response and inflammation. With its exceptional specificity and sensitivity, this antibody is essential for a wide range of experiments and applications.
The CD183/CXCR3 protein is a G-protein coupled receptor that is primarily expressed on immune cells such as T cells, B cells, and natural killer cells. It binds to the chemokines CXCL9, CXCL10, and CXCL11, which are involved in recruiting immune cells to sites of inflammation. The CD183/CXCR3 protein is also involved in regulating T cell migration and activation, making it a key player in immune response and inflammation.
The Anti-CD183/CXCR3 Polyclonal Antibody is an essential tool for researchers studying immune response, inflammation, and autoimmune diseases. It is commonly used in flow cytometry, immunohistochemistry, and western blotting techniques to detect and quantify the expression of the CD183/CXCR3 protein. This antibody is also useful for studying the role of CD183/CXCR3 in various diseases, such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease.
– Inflammation and Immune Response: The Anti-CD183/CXCR3 Polyclonal Antibody can be used to study the expression and function of CD183/CXCR3 in various immune cells. It can help researchers understand the role of this protein in immune response and inflammation, providing valuable insights into the development of new therapies for inflammatory diseases.
– Autoimmune Diseases: The CD183/CXCR3 protein has been implicated in the pathogenesis of various autoimmune diseases. By using the Anti-CD183/CXCR3 Polyclonal Antibody, researchers can investigate the expression and activity of this protein in autoimmune conditions, potentially leading to the development of novel treatments.
– Drug Discovery: The CD183/CXCR3 protein is a potential target for drug development, particularly in the field of immunotherapy. The Anti-CD183/CXCR3 Polyclonal Antibody can be used to screen for potential drug candidates that can modulate the activity of this protein, providing a valuable tool for drug discovery.
In conclusion, the Anti-CD183/CXCR3 Polyclonal Antibody is a highly specific and sensitive tool for studying the CD183/CXCR3 protein. Its applications in immune response, inflammation, and autoimmune diseases make it a valuable asset for researchers in the biotechnology field. With its exceptional performance and versatility, this antibody is a must-have for any laboratory conducting targeted biomedical research. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A22161. For research use only.
Target: C-X-C chemokine receptor type 3; CXC-R3; CXCR-3; Interferon-inducible protein 10 receptor; IP-10 receptor; CD183; Cxcr3; Cmkar3; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| C-X-C chemokine receptor type 3; CXC-R3; CXCR-3; Interferon-inducible protein 10 receptor; IP-10 receptor; CD183; Cxcr3; Cmkar3 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
